List of insiders holdings for Jaguar Health Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | NAPO PHARMACEUTICALS INC 10% Owner |
2016-03-29 16:31:21 | 2,666,666 0 |
2,666,666 | Form 13G |
2 | Sagard Capital Partners L.P. Sagard Capital Partners GP Inc. Sagard Capital Partners Management Corp Former 10% beneficial owner |
2021-02-12 16:30:38 | 1,910,043 0 |
1,910,043 | Form 13G |
3 | BVCF Management Ltd. Kunlun Pharmaceuticals Ltd. BVCF III L.P. BVCF III-A L.P. 10% Owner |
2015-05-18 18:03:05 | 0 1,522,881 |
1,522,881 | Form 4 |
4 | GLASER JONATHAN M Former 10% Owner |
2019-08-23 16:03:27 | 338,107 0 |
338,107 | Form 13G |
5 | Wright Karen Steil CFO and Treasurer |
2019-07-26 16:48:30 | 303,932 0 |
303,932 | Form 4 |
6 | Ezralow Bryan Bryan Ezralow 1994 Trust dated December 22 1994 Former 10% Owner |
2019-08-26 15:38:07 | 282,850 0 |
282,850 | Form 13G |
7 | Hauser Michael Chf Veterinarian, Clinical Ops |
2015-05-18 18:14:35 | 73,000 0 |
73,000 | Form 4 |
8 | BOCHNOWSKI JAMES J Director |
2025-04-02 20:10:04 | 0 54,004 |
54,004 | Form 4 |
9 | Kamphuis Folkert W. Director |
2018-06-06 21:42:41 | 53,164 0 |
53,164 | Form 4 |
10 | Azhir Ari Director |
2018-06-06 21:46:26 | 39,286 0 |
39,286 | Form 4 |
11 | Nantucket Investments Ltd Burford Capital Ltd 10% Owner |
2020-03-31 10:53:39 | 36,362 0 |
36,362 | Form 13G |
12 | Jayasuriya Anula Director |
2024-10-10 21:53:44 | 21,000 0 |
21,000 | Form 4 |
13 | Brianceau Philippe Chief Veterinary Officer |
2016-04-05 19:56:23 | 20,000 0 |
20,000 | Form 4 |
14 | MICEK JOHN Director |
2025-04-02 20:10:19 | 18,000 0 |
18,000 | Form 4 |
15 | Siegel Jonathan B. Director |
2025-04-02 20:10:08 | 0 18,000 |
18,000 | Form 4 |
16 | CONTE LISA A CEO and President |
2025-04-02 20:10:06 | 18,000 0 |
18,000 | Form 4 |
17 | Wolin Jonathan S. See Remarks |
2025-04-02 20:10:05 | 18,000 0 |
18,000 | Form 4 |
18 | Kallassy John A CFO, COO, Treasurer |
2015-05-18 18:10:44 | 13,365 0 |
13,365 | Form 4 |
19 | Qiu Jiahao Director |
2018-06-06 21:40:41 | 12,965 0 |
12,965 | Form 4 |
20 | Yang Zhi Director |
2018-06-06 21:43:57 | 12,965 0 |
12,965 | Form 4 |
21 | Divis Gregory J Director |
2022-05-18 16:33:45 | 12,133 0 |
12,133 | Form 4 |
22 | Lizak Carol R. Chief Financial Officer |
2025-04-02 20:10:03 | 10,800 0 |
10,800 | Form 4 |
23 | Chaturvedi Pravin R Chief Scientific Officer |
2025-04-02 20:10:05 | 7,200 0 |
7,200 | Form 4 |
24 | King Steven R. See Remarks |
2025-04-02 20:10:09 | 7,200 0 |
7,200 | Form 4 |
25 | Waltzman Roger J. Chief Scientific Officer |
2016-12-21 14:41:07 | 2,866 0 |
2,866 | Form 4 |
26 | MacNaughtan Murray David Former director Director |
2020-02-27 17:16:50 | 0 0 |
0 | Form 4 |
27 | JOHNSON JEFFERY C. Former director Director |
2020-02-27 17:15:35 | 0 0 |
0 | Form 4 |